Indefinite Delivery Contract SPE2DX20D9544

This federal Indefinite Delivery Contract (IDC) with award number SPE2DX20D9544 was awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,999,999 single-award IDC, valid through December 2025, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The IDC covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This includes specialized pharmaceuticals like Xolair, Trikafta, Keytruda, Botox, and Nucala. The contract allows the DLA to directly procure these critical pharmaceutical items and pharmacy services for the Department of Defense healthcare system, positioning DMS Pharmaceutical Group as a key supplier in the federal pharmaceutical supply chain.